A new device rapidly analyzes blood for medically relevant genetic variations.
"A desktop instrument recently approved by the U.S. Food and Drug Administration might finally bring pharmacogenomic testing--the use of a patient's genetic information for drug prescription decisions--to the mainstream. The device, made by Nanosphere, a startup based in Northbrook, IL, can, in a matter of hours, detect genetic variations in blood that modulate the effectiveness of some drugs. Dubbed Verigene, the technology employs a combination of microfluidics and nanotechnology, housed in a single plastic cartridge, to pull DNA from a blood sample and then screen it for the relevant sequences."
News and views from Brennemann Library are for the physicians, nurses and allied health professionals at Children's Memorial Hospital to foster the patient care, education, research and advocacy missions of Children's Memorial Hospital, Chicago, Illinois. Articles posted range from those found in mainstream media for lay audiences to those selected from professional, peer-reviewed journals. The Brennemann Blog does not endorse the information found in these articles.
On the right is a selection of recent articles of medical News, E-medicine, Nursing, Pediatrics, Hospitals and Heath Care and Patient Safety.
NEWS
E - MEDICINE
PEDIATRICS
HOSPITALS and HEALTH CARE
text/javascript">